News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,282 Results
Type
Article (8046)
Company Profile (140)
Press Release (476191)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166747)
Career Advice (304)
Deals (25743)
Drug Delivery (7)
Drug Development (52880)
Employer Resources (14)
FDA (9761)
Job Trends (8574)
News (238205)
Policy (17898)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (485)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33156)
ALS (104)
Alzheimer's disease (973)
Antibody-drug conjugate (ADC) (262)
Approvals (10367)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6960)
BIO (36)
BIOSECURE Act (1)
Biosimilars (108)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (506)
Cancer (3625)
Cardiovascular disease (217)
Career advice (245)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47842)
Collaboration (1236)
Commercialization (3)
Compensation (1444)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (735)
Cystic fibrosis (85)
Data (5606)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (341)
Diagnostics (4175)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73564)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87575)
Executive appointments (697)
FDA (12362)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (908)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (289)
Government (941)
Grass and pollen (2)
Guidances (281)
Healthcare (9312)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (155)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (41)
IPO (12390)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (7)
Liver cancer (44)
Longevity (15)
Lung cancer (503)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (525)
Marketing (8)
MASH (118)
Medical device (8650)
Medtech (8790)
Mergers & acquisitions (14379)
Metabolic disorders (703)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1815)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (222)
Opinion (10)
Ovarian cancer (158)
Pain (170)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (472)
Patient recruitment (501)
Peanut (31)
People (41208)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15456)
Phase 2 (21371)
Phase 3 (14389)
Pipeline (7139)
Policy (18)
Postmarket research (1570)
Preclinical (6536)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (569)
Real estate (3019)
Recruiting (6)
Regulatory (14780)
Reports (19)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (152)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (317)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (58)
Last 7 days (462)
Last 30 days (1608)
Last 365 days (19147)
2026 (11904)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34589)
2021 (37167)
2020 (33481)
2019 (23279)
2018 (17475)
2017 (18766)
2016 (17920)
2015 (24263)
2014 (21683)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (72)
Alaska (2)
Arizona (299)
Arkansas (11)
Asia (17879)
Australia (2097)
California (11847)
Canada (3114)
China (514)
Colorado (479)
Connecticut (405)
Delaware (207)
Europe (24619)
Florida (1770)
Georgia (372)
Hawaii (3)
Idaho (46)
Illinois (695)
India (48)
Indiana (314)
Iowa (14)
Japan (396)
Kansas (100)
Kentucky (30)
Louisiana (26)
Maine (26)
Maryland (1187)
Massachusetts (7803)
Michigan (306)
Minnesota (558)
Mississippi (4)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2600)
New Mexico (12)
New York (2799)
North Carolina (1262)
North Dakota (4)
Northern California (5929)
Ohio (275)
Oklahoma (14)
Oregon (18)
Pennsylvania (2239)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4915)
Tennessee (119)
Texas (1914)
United States (38524)
Utah (357)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (918)
West Virginia (1)
Wisconsin (73)
484,282 Results for "restorbio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Genetown
resTORbio to Present at Upcoming Investor Conferences
resTORbio, Inc. announced that management will present at two upcoming investor conferences
November 27, 2019
·
1 min read
Deals
Adicet Announces Completion of Merger with resTORbio
Adicet Bio, Inc., a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the completion of its previously announced merger with resTORbio, Inc. (previously trading on Nasdaq under the symbol “TORC”)
September 15, 2020
·
7 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
Press Releases
Biogen Completes Acquisition of RayThera Inc.
August 7, 2026
·
7 min read
Business
resTORbio Provides Corporate Update and Reports Second Quarter 2020 Financial Results
resTORbio, Inc., a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, provided a corporate update and reported financial results for the second quarter ended June 30, 2020.
July 30, 2020
·
11 min read
Business
resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
resTORbio, Inc. reported financial results for the fourth quarter and full year ended December 31, 2019.
March 12, 2020
·
9 min read
Press Releases
Therma Bright Inc. Completes Debt Settlements
July 30, 2026
·
3 min read
Press Releases
Utah Medical Products, Inc. Announces Quarterly Dividend
August 4, 2026
·
1 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
1 of 48,429
Next
